165 related articles for article (PubMed ID: 38467612)
1. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo.
Ma ZR; Li HP; Cai SZ; Du SY; Chen X; Yao J; Cao X; Zhen YF; Wang Q
Cell Death Dis; 2023 May; 14(5):307. PubMed ID: 37147302
[TBL] [Abstract][Full Text] [Related]
3. TIMM44 is a potential therapeutic target of human glioma.
Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
[TBL] [Abstract][Full Text] [Related]
4. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
[TBL] [Abstract][Full Text] [Related]
5. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
[TBL] [Abstract][Full Text] [Related]
6. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth.
Jin L; Zhu J; Yao L; Shen G; Xue BX; Tao W
Cell Death Dis; 2023 Aug; 14(8):537. PubMed ID: 37604912
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
[TBL] [Abstract][Full Text] [Related]
8. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
[TBL] [Abstract][Full Text] [Related]
9. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
[TBL] [Abstract][Full Text] [Related]
10. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
Zhang JJ; Cai LJ; Pang K; Dong Y; Zhang ZG; Li BB; Li R; Han CH
Clin Transl Oncol; 2021 Mar; 23(3):601-611. PubMed ID: 32691366
[TBL] [Abstract][Full Text] [Related]
11. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
[TBL] [Abstract][Full Text] [Related]
12. Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
Zhao Z; Zhang P; Li W; Wang D; Ke C; Liu Y; Ho JC; Cheng PN; Xu S
Oxid Med Cell Longev; 2021; 2021():5510663. PubMed ID: 33791071
[TBL] [Abstract][Full Text] [Related]
13. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
Li SP; Ou L; Zhang Y; Shen FR; Chen YG
Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
[TBL] [Abstract][Full Text] [Related]
14. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.
Shahjee HM; Koch KR; Guo L; Zhang CO; Keay SK
J Exp Clin Cancer Res; 2010 Dec; 29(1):160. PubMed ID: 21143984
[TBL] [Abstract][Full Text] [Related]
16. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
17. β-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study.
Yu X; Liao B; Zhu P; Cheng S; Du Z; Jiang G
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22863. PubMed ID: 34318533
[TBL] [Abstract][Full Text] [Related]
18. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
Chen YT; Yang CC; Shao PL; Huang CR; Yip HK
J Pineal Res; 2019 Jan; 66(1):e12536. PubMed ID: 30372570
[TBL] [Abstract][Full Text] [Related]
19. Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway.
Yuan G; Chen X; Liu Z; Wei W; Shu Q; Abou-Hamdan H; Jiang L; Li X; Chen R; Désaubry L; Zhou F; Xie D
J Exp Clin Cancer Res; 2018 Feb; 37(1):21. PubMed ID: 29415747
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
